{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:49:14Z","timestamp":1792147754410,"version":"4.4.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital (Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stenotrophomonas maltophilia is a multidrug-resistant opportunistic pathogen associated with substantial in-hospital mortality. However, data supporting the efficacy of treating S. maltophilia infections using a combination of antimicrobials remain inconclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess whether adjunctive minocycline improves clinical outcomes of S. maltophilia infections compared with standard monotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This randomized, double-blind, placebo-controlled trial was conducted at Siriraj Hospital, Thailand. Adults with confirmed S. maltophilia infections were randomized to receive minocycline or a matching placebo in addition to monotherapy with either levofloxacin or trimethoprim\/sulfamethoxazole.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This trial enrolled 112 patients (71.4% [n\u200a=\u200a80\/112] of patients requiring an intensive care unit [ICU] and 66.1% [n\u200a=\u200a74\/112] of patients were diagnosed with ventilator-associated pneumonia [VAP]). Baseline demographic and clinical characteristics were balanced between intervention and control groups. Adjunctive minocycline did not significantly reduce 28-day-mortality (n\u200a=\u200a24\/55[43.6%] vs n\u200a=\u200a22\/57[38.6%], P\u200a=\u200a0.590) but did achieve significantly higher microbiological response rates at early assessment (n\u200a=\u200a25\/55[45.5%] vs n\u200a=\u200a8\/57[14.0%], P\u200a&amp;lt;\u200a0.001) and the end of treatment (n\u200a=\u200a44\/55[80.0%] vs n\u200a=\u200a32\/57[56.1%], P\u200a=\u200a0.023). In contrast, clinical response rates did not differ between groups at either 72\u2005h after the start of study treatment or the end of study treatment. In multivariable analysis, two factors were independently associated with 28-day mortality: history of antibiotic use before admission (adjusted odds ratio [aOR]: 7.65, 95% confidence interval [CI]: 2.04\u201328.76; P\u200a=\u200a0.030) and septic shock (aOR: 7.24, 95% CI: 2.75\u201319.23; P\u200a&amp;lt;\u200a0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although adding minocycline to either levofloxacin or trimethoprim\/sulfamethoxazole therapy enhanced microbiological eradication, it did not confer a measurable survival or clinical advantage. Combination therapy was well tolerated. This study is potentially of interest to those treating ICU patients, as the majority of infections were VAP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jacamr\/dlag224","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:46:13Z","timestamp":1790855173000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of combination therapy with minocycline for treating\n                    <i>Stenotrophomonas maltophilia<\/i>\n                    infections"],"prefix":"10.1093","volume":"8","author":[{"given":"Tuvanont","family":"Pongdumbun","sequence":"first","affiliation":[{"name":"Golden Jubilee Medical Center, Faculty of Medicine, Siriraj Hospital, Mahidol University Department of Internal Medicine, , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Rongrungruang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6549-9621","authenticated-orcid":false,"given":"Adhiratha","family":"Boonyasiri","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"2026101606201433400_dlag224-B1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2026101606201433400_dlag224-B2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00030-19","article-title":"Advances in the microbiology of Stenotrophomonas maltophilia","volume":"34","author":"Brooke","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"2026101606201433400_dlag224-B3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jhin.2008.05.020","article-title":"Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review","volume":"70","author":"Paez","year":"2008","journal-title":"J Hosp Infect"},{"key":"2026101606201433400_dlag224-B4","doi-asserted-by":"publisher","first-page":"e4375","DOI":"10.1097\/MD.0000000000004375","article-title":"Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia","volume":"95","author":"Jeon","year":"2016","journal-title":"Medicine"},{"key":"2026101606201433400_dlag224-B5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3855\/jidc.4236","article-title":"Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China","volume":"8","author":"Xun","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"2026101606201433400_dlag224-B6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.eimc.2010.05.001","article-title":"Interpretive Reading of the non-fermenting gram-negative bacilli antibiogram","volume":"28","author":"Vila","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2026101606201433400_dlag224-B7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2217\/fmb.09.45","article-title":"Stenotrophomonas maltophilia drug resistance","volume":"4","author":"Sanchez","year":"2009","journal-title":"Future Microbiol"},{"key":"2026101606201433400_dlag224-B8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026101606201433400_dlag224-B9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2026101606201433400_dlag224-B10","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2147\/IDR.S253949","article-title":"Stenotrophomonas maltophilia infections: clinical characteristics and factors associated with mortality of hospitalized patients","volume":"13","author":"Insuwanno","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2026101606201433400_dlag224-B11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00788-19","article-title":"Clinical and microbiologic outcomes in patients with monomicrobial Stenotrophomonas maltophilia infections","volume":"63","author":"Nys","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026101606201433400_dlag224-B12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2026101606201433400_dlag224-B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"2026101606201433400_dlag224-B14","doi-asserted-by":"publisher","first-page":"S374","DOI":"10.1093\/cid\/ciu613","article-title":"A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections","volume":"59 Suppl 6","author":"Ritchie","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026101606201433400_dlag224-B15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-19","article-title":"In vitro activity of minocycline against US isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018","volume":"63","author":"Flamm","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026101606201433400_dlag224-B16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026101606201433400_dlag224-B17","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2013definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Critical Care"},{"key":"2026101606201433400_dlag224-B18","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/jac\/dkz116","article-title":"Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia","volume":"74","author":"Shah","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026101606201433400_dlag224-B19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.eimce.2022.06.014","article-title":"Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria","volume":"41","author":"Pintado","year":"2023","journal-title":"Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)"},{"key":"2026101606201433400_dlag224-B20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/antibiotics12050910","article-title":"Stenotrophomonas maltophilia infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options","volume":"12","author":"Maraolo","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"2026101606201433400_dlag224-B21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00559-20","article-title":"Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia","volume":"64","author":"Biagi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026101606201433400_dlag224-B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diagmicrobio.2004.09.002","article-title":"Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia","volume":"51","author":"Zelenitsky","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026101606201433400_dlag224-B23","first-page":"194","article-title":"Clinical evaluation of intravenous minocycline","volume":"15","author":"Rogers","year":"1977","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"2026101606201433400_dlag224-B24","first-page":"556","article-title":"Activity in vitro and pharmacokinetics of minocycline (author's transl)","volume":"26","author":"Simon","year":"1976","journal-title":"Arzneimittelforschung"},{"key":"2026101606201433400_dlag224-B25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/QCO.0000000000000975","article-title":"Treatment approaches for severe Stenotrophomonas maltophilia infections","volume":"36","author":"Mojica","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"2026101606201433400_dlag224-B26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijid.2020.09.396","article-title":"Stenotrophomonas maltophilia: attributable mortality may be overestimated","volume":"101","author":"Kannangara","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2026101606201433400_dlag224-B27","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1186\/s12879-019-4394-4","article-title":"Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2026101606201433400_dlag224-B28","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.2147\/IDR.S371129","article-title":"Risk factors for mortality in hospitalized patients with Stenotrophomonas maltophilia bacteremia","volume":"15","author":"Jian","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2026101606201433400_dlag224-B29","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.3390\/jcm11113085","article-title":"Clinical characteristics, outcomes, and risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia","volume":"11","author":"Kanchanasuwan","year":"2022","journal-title":"J Clin Med"},{"key":"2026101606201433400_dlag224-B30","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/antibiotics11121788","article-title":"Combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis","volume":"11","author":"Prawang","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026101606201433400_dlag224-B31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1574886316666210120090446","article-title":"Adverse reactions induced by minocycline: a review of literature","volume":"16","author":"Dominic","year":"2021","journal-title":"Curr Drug Saf"},{"key":"2026101606201433400_dlag224-B32","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","article-title":"Comparative safety of tetracycline, minocycline, and doxycycline","volume":"133","author":"Shapiro","year":"1997","journal-title":"Arch Dermatol"},{"key":"2026101606201433400_dlag224-B33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cid\/cix833","article-title":"Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and metaanalysis","volume":"66","author":"Tariq","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026101606201433400_dlag224-B34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jiac.2018.03.011","article-title":"Risk factors for death from Stenotrophomonas maltophilia bacteremia","volume":"24","author":"Osawa","year":"2018","journal-title":"J Infect Chemother"},{"key":"2026101606201433400_dlag224-B35","first-page":"84","article-title":"Risk factors for mortality in patients with Stenotrophomonas maltophilia infection in Hatyai Hospital","volume":"15","author":"Nitchot","year":"2023","journal-title":"Princess Naradhiwas Univ J"},{"key":"2026101606201433400_dlag224-B36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13756-023-01234-y","article-title":"Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study","volume":"12","author":"Yi","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"2026101606201433400_dlag224-B37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.11622\/smedj.2017079","article-title":"Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65","volume":"59","author":"Zhang","year":"2018","journal-title":"Singapore Med J"},{"issue":"Suppl 1","key":"2026101606201433400_dlag224-B38","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1093\/ofid\/ofy293","article-title":"Antimicrobial susceptibility of Acinetobacter calcoaceticus\u2013Acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY antimicrobial surveillance program (1997\u20132016)","volume":"6","author":"Gales","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2026101606201433400_dlag224-B39","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/antibiotics10101226","article-title":"Antimicrobial treatment strategies for Stenotrophomonas maltophilia: a focus on novel therapies","volume":"10","author":"Gibb","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2026101606201433400_dlag224-B40","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1163439","article-title":"Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"10","author":"Banar","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026101606201433400_dlag224-B41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13054-019-2649-5","article-title":"Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study","volume":"23","author":"Guerci","year":"2019","journal-title":"Critical Care"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/5\/dlag224\/72037035\/dlag224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/5\/dlag224\/72037035\/dlag224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:20:17Z","timestamp":1792146017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlag224\/8931459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlag224","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"dlag224"}}